Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joseph Todisco Insider Profile
11 Followers
Joseph Todisco, EVP at Amneal Pharmaceuticals, holds 325.86K shares in Cormedix (Ticker: CRMD), holds 327.19K shares in Amneal Pharmaceuticals (Ticker: AMRX).
Profitable Transactions
8 out of 9 Profitable Transactions
Average Return
+29.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joseph Todisco holds in companies
Most Profitable Insider Trade
The most profitable trade made by Joseph Todisco
Joseph Todisco's Trading History
Amneal Pharmaceuticals
May 10, 2022
EVP
Uninformative Buy
9.79K
$2.55M
Cormedix
May 13, 2024
CEO, Director
Uninformative Sell
139.50K
$2.79M
List of latest transactions for each holding click on a transaction to see Joseph Todisco's performance on stock
You May Also Like
Joseph Todisco insider profile FAQ
What is the percentage of profitable transactions made by Joseph Todisco?
The percentage of profitable transactions made by Joseph Todisco is 89%.
What is the average return per transaction made by Joseph Todisco?
The average return per transaction made by Joseph Todisco is 29.30%.
What stocks does Joseph Todisco hold?
Joseph Todisco holds: AMRX, CRMD stocks.
What was Joseph Todisco’s latest transaction?
Joseph Todisco latest transaction was an Uninformative Sell of $139.50K.
What was Joseph Todisco's most profitable transaction?
Joseph Todisco’s most profitable transaction was an Informative Buy of CRMD stock on March 14, 2024. The return on the trade was 127.20%.
What is Joseph Todisco's role in Amneal Pharmaceuticals?
Joseph Todisco's role in Amneal Pharmaceuticals is EVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.